Report : South America Multimodal Image Fusion Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Preclinical Multimodal Imaging and Clinical Multimodal Imaging), and Application (Hospitals, Diagnostic Centers, and Academic and Research Institutes)
Hospitals Segment to Dominate SAM Multimodal Image Fusion Software Market during 2021–2028
According to a new market research study on “SAM Multimodal Image Fusion Software Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type and Application” is expected to reach US$ 24.91 million by 2028 from US$ 15.58 million in 2021. The market is estimated to grow at a CAGR of 6.9% from 2021 to 2028. The report provides trends prevailing in the SAM multimodal image fusion software market along with the drivers and restraints pertaining to the market growth. Growing government and private spending on healthcare infrastructure is the major factor driving the growth of the SAM multimodal image fusion software market. However, issues associated with the high cost of associated diagnostics equipment hinder the growth of SAM multimodal image fusion software market.
The SAM multimodal image fusion software market is segmented into type, application and country. In terms of type, the multimodal image fusion software market is bifurcated into preclinical multimodal imaging and clinical multimodal imaging. The clinical multimodal imaging segment dominated the market in 2020 and preclinical multimodal imaging segment is expected to be the fastest growing during the forecast period. Based on application, the multimodal image fusion software market is categorized into hospitals, diagnostic centers, and academic and research institutes. The hospitals segment dominated the market in 2020 and diagnostic centers segment is expected to be the fastest growing during the forecast period. Based on country, SAM multimodal image fusion software market is classified into Brazil, Argentina, and Rest of SAM.
Brazil has reported the largest number of cases of COVID-19 in South America, followed by Ecuador, Chile, Peru, and Argentina, among others. The pandemic has compelled several country governments to impose lockdowns and suspend economic activities to contain the spread of the virus. Brazil has the most lucrative healthcare system in among all South American countries. The country has observed high investments in medical devices and other healthcare technology over the years. The healthcare sector in several South American countries continued to adopt advanced technologies amid the COVID-19 pandemic, as there were no significant disruptions in the healthcare sector. Thus, there has been a negligible impact of the pandemic on the multimodal image fusion software market in the region.
Brainlab AG; Bruker Corporation; Carl Zeiss Meditec; and PerkinElmer Inc. are among the leading companies in the SAM multimodal image fusion software market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2018, Bruker Corporation had launched ParaVision 360 preclinical imaging software. It is the most advanced research-grade software for preclinical MRI and had also been extended to nuclear molecular imaging.
SAM Multimodal Image Fusion Software Market, By Country, 2020 and 2028 (%) 
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com